The latest report by IMARC, titled “Medical Footwear Market Report by End User (Men, Women), Distribution Channel (Offline, Online), and Region 2025-2033”, finds that the global medical footwear market size reached USD 11.2 Billion in 2024. Medical footwear refers to garments that are especially designed to help in the treatment of numerous foot-related medical ailments. It assists with various health conditions, such as plantar fasciitis, arthritis, bunions and hallux valgus, and Achilles tendonitis. Individuals diagnosed with diabetes and flat feet also use this product. It ensures proper blood circulation in the patients’ body while offering improved support to their feet. In recent years, medical footwear has gained popularity across the globe as it can also be customized as per the specific requirements of consumers.
Global Medical Footwear Market Trends:
One of the primary factors driving the market is the increasing number of individuals diagnosed with foot-related issues, including corns, foot and ankle injuries, flat feet, and arthritis. Nowadays, individuals are also increasingly investing in good-quality medical footwear that offers a cushion to the entire foot while providing support, mobility, and healthy blood circulation. Other than this, military combats performing high-intensity outdoor activities, long-distance runners, and sports enthusiasts are more prone to knee pain and ankle sprains, thus requiring medical footwear to recover and heal feet. Besides this, poorly controlled blood sugar levels among individuals can damage the nerves and vessels present in the feet and legs, leading to the development of peripheral neuropathy. On account of this, diabetes patients prefer the adoption of medical footwear. Moreover, expanding income levels of the masses, in confluence with the easy availability of this product through various pharmacies and online retail channels, is catalyzing the market growth. Looking forward, the market value is projected to reach USD 17.3 Billion by 2033, expanding at a CAGR of 4.58% during 2025-2033.
Market Summary:
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Segment Coverage | End User, Distribution Channel, Region |
Region Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | Aetrex Worldwide Inc., Darco International Inc. (Wright Medical Group N.V.), Djo LLC (Colfax Corporation), Dr. Foot Inc., Dr. Zen Inc., Drewshoe Incorporated, Duna Srl, Gravity Defyer Corp., Horng Shin Footwear Co., Mephisto S.A.S, New Balance Inc., Orthofeet Inc. and Podartis srl |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
30 N Gould St, Ste
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800